Global Fever Panel Instructions for Use

Total Page:16

File Type:pdf, Size:1020Kb

Global Fever Panel Instructions for Use DFA2-ASY-0004 BioFire ® Global Fever Panel Instructions for Use The Symbols Glossary is provided on Page 42 of this booklet. For In Vitro Diagnostic Use Manufactured by BioFire Defense, LLC 79 West 4500 South, Suite 14 Salt Lake City, UT 84107 USA TABLE OF CONTENTS INTENDED USE ................................................................................................................................ 1 SUMMARY AND EXPLANATION OF THE TEST ............................................................................ 1 Summary of Detected Organisms ................................................................................................. 2 Bacteria ...................................................................................................................................... 2 Viruses ....................................................................................................................................... 2 Protozoa ..................................................................................................................................... 2 PRINCIPLE OF THE PROCEDURE .................................................................................................. 4 MATERIALS PROVIDED .................................................................................................................. 5 MATERIALS REQUIRED BUT NOT PROVIDED ............................................................................. 5 WARNINGS AND PRECAUTIONS ................................................................................................... 5 General Precautions ..................................................................................................................... 5 Safety Precautions ........................................................................................................................ 5 Laboratory Precautions ................................................................................................................. 6 Precaution Related to Public Health ............................................................................................. 7 REAGENT STORAGE, HANDLING, AND STABILITY .................................................................... 7 SAMPLE REQUIREMENTS .............................................................................................................. 8 PROCEDURE .................................................................................................................................... 8 Step 1: Prepare Pouch .................................................................................................................. 9 Step 2: Hydrate Pouch .................................................................................................................. 9 Step 3: Prepare Sample Mix ....................................................................................................... 10 Step 4: Load Sample Mix ............................................................................................................ 11 Step 5: Run Pouch ...................................................................................................................... 12 QUALITY CONTROL ....................................................................................................................... 13 Process Controls ......................................................................................................................... 13 Monitoring Test System Performance ......................................................................................... 13 External Controls ......................................................................................................................... 13 INTERPRETATION OF RESULTS .................................................................................................. 14 Assay Interpretation .................................................................................................................... 14 Organism Interpretation .............................................................................................................. 15 Leptospira spp. Reporting ........................................................................................................ 16 Chikungunya virus Reporting ................................................................................................... 16 Dengue virus Reporting ........................................................................................................... 16 Plasmodium Reporting ............................................................................................................. 16 BioFire Global Fever Panel Test Report ..................................................................................... 18 Results Explanation and Required Actions ................................................................................. 20 CLEANING MATERIALS ................................................................................................................ 21 DECONTAMINATION PROCEDURES ........................................................................................... 21 Pouch Loading Station Decontamination .................................................................................... 21 BioFire® Global Fever Panel - Instructions for Use i BioFire Defense, LLC Decontamination Related to Pouch Leakage .............................................................................. 21 Instrument Decontamination ....................................................................................................... 22 Pouch Loading Chamber Decontamination ............................................................................. 22 Instrument Exterior Decontamination ...................................................................................... 22 Decontamination of Bench Tops and Other Areas ..................................................................... 22 Check Function of Decontaminated Instrument .......................................................................... 22 Check for Environmental Contamination .................................................................................... 23 LIMITATIONS .................................................................................................................................. 24 EXPECTED VALUES ...................................................................................................................... 25 PERFORMANCE CHARACTERISTICS ......................................................................................... 27 Clinical Performance ................................................................................................................... 27 Limit of Detection......................................................................................................................... 29 Analytical Reactivity (Inclusivity) ................................................................................................. 31 Analytical Reactivity (Cross-Reactivity and Exclusivity).............................................................. 35 Reproducibility ............................................................................................................................. 38 Interference ................................................................................................................................. 39 APPENDIX A ................................................................................................................................... 42 Symbols Glossary ....................................................................................................................... 42 APPENDIX B ................................................................................................................................... 43 Contact and Legal Information .................................................................................................... 43 Revision History .......................................................................................................................... 43 APPENDIX C ................................................................................................................................... 44 References .................................................................................................................................. 44 BioFire® Global Fever Panel - Instructions for Use ii BioFire Defense, LLC INTENDED USE The BioFire® Global Fever Panel is a qualitative, multiplexed, nucleic acid-based in vitro diagnostic test intended for use with the FilmArray® 2.0 system. The BioFire Global Fever Panel detects and identifies selected bacterial, viral, and protozoan nucleic acids directly from EDTA whole blood collected from individuals with signs and/or symptoms of acute febrile illness or recent acute febrile illness and known or suspected exposure to the following target pathogens: Leptospira spp., chikungunya virus, dengue virus (serotypes 1, 2, 3 and 4), and Plasmodium spp. (including species differentiation of Plasmodium falciparum and Plasmodium vivax/ovale). Evaluation for more common causes of acute febrile illness (e.g., infections of the upper and lower respiratory tract or gastroenteritis, as well as non-infectious causes) should be considered prior to evaluation with this panel. Results are meant to be used in conjunction with other clinical, epidemiologic, and
Recommended publications
  • Compendium of Measures to Control Chlamydia Psittaci Infection Among
    Compendium of Measures to Control Chlamydia psittaci Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017 Author(s): Gary Balsamo, DVM, MPH&TMCo-chair Angela M. Maxted, DVM, MS, PhD, Dipl ACVPM Joanne W. Midla, VMD, MPH, Dipl ACVPM Julia M. Murphy, DVM, MS, Dipl ACVPMCo-chair Ron Wohrle, DVM Thomas M. Edling, DVM, MSpVM, MPH (Pet Industry Joint Advisory Council) Pilar H. Fish, DVM (American Association of Zoo Veterinarians) Keven Flammer, DVM, Dipl ABVP (Avian) (Association of Avian Veterinarians) Denise Hyde, PharmD, RP Preeta K. Kutty, MD, MPH Miwako Kobayashi, MD, MPH Bettina Helm, DVM, MPH Brit Oiulfstad, DVM, MPH (Council of State and Territorial Epidemiologists) Branson W. Ritchie, DVM, MS, PhD, Dipl ABVP, Dipl ECZM (Avian) Mary Grace Stobierski, DVM, MPH, Dipl ACVPM (American Veterinary Medical Association Council on Public Health and Regulatory Veterinary Medicine) Karen Ehnert, and DVM, MPVM, Dipl ACVPM (American Veterinary Medical Association Council on Public Health and Regulatory Veterinary Medicine) Thomas N. Tully JrDVM, MS, Dipl ABVP (Avian), Dipl ECZM (Avian) (Association of Avian Veterinarians) Source: Journal of Avian Medicine and Surgery, 31(3):262-282. Published By: Association of Avian Veterinarians https://doi.org/10.1647/217-265 URL: http://www.bioone.org/doi/full/10.1647/217-265 BioOne (www.bioone.org) is a nonprofit, online aggregation of core research in the biological, ecological, and environmental sciences. BioOne provides a sustainable online platform for over 170 journals and books published by nonprofit societies, associations, museums, institutions, and presses. Your use of this PDF, the BioOne Web site, and all posted and associated content indicates your acceptance of BioOne’s Terms of Use, available at www.bioone.org/page/terms_of_use.
    [Show full text]
  • Information to Users
    INFORMATION TO USERS This manuscript bas been reproJuced from the microfilm master. UMI films the text directly ftom the original or copy submitted. Thus, sorne thesis and dissertation copies are in typewriter face, while others may be itom any type ofcomputer printer. The quality oftbis reproduction is depeDdeDt apoD the quality of the copy sablDitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthlough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will he noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand corner and continuing trom left to right in equal sections with sma1l overlaps. Each original is a1so photographed in one exposure and is included in reduced fonn at the back orthe book. Photographs ineluded in the original manuscript have been reproduced xerographically in this copy. Higher quality 6" x 9" black and white photographie prints are available for any photographs or illustrations appearing in this copy for an additional charge. Contact UMI directly to order. UMI A Bell & Howell Information Company 300 North Zeeb Raad, ADn AJbor MI 48106-1346 USA 313n61-4700 8OO1S21~ NOTE TO USERS The original manuscript received by UMI contains pages with slanted print. Pages were microfilmed as received. This reproduction is the best copy available UMI Oral spirochetes: contribution to oral malodor and formation ofspherical bodies by Angela De Ciccio A thesis submitted to the Faculty ofGraduate Studies and Research, McGill University, in partial fulfillment ofthe requirements for the degree ofMaster ofScience.
    [Show full text]
  • Table S4. Phylogenetic Distribution of Bacterial and Archaea Genomes in Groups A, B, C, D, and X
    Table S4. Phylogenetic distribution of bacterial and archaea genomes in groups A, B, C, D, and X. Group A a: Total number of genomes in the taxon b: Number of group A genomes in the taxon c: Percentage of group A genomes in the taxon a b c cellular organisms 5007 2974 59.4 |__ Bacteria 4769 2935 61.5 | |__ Proteobacteria 1854 1570 84.7 | | |__ Gammaproteobacteria 711 631 88.7 | | | |__ Enterobacterales 112 97 86.6 | | | | |__ Enterobacteriaceae 41 32 78.0 | | | | | |__ unclassified Enterobacteriaceae 13 7 53.8 | | | | |__ Erwiniaceae 30 28 93.3 | | | | | |__ Erwinia 10 10 100.0 | | | | | |__ Buchnera 8 8 100.0 | | | | | | |__ Buchnera aphidicola 8 8 100.0 | | | | | |__ Pantoea 8 8 100.0 | | | | |__ Yersiniaceae 14 14 100.0 | | | | | |__ Serratia 8 8 100.0 | | | | |__ Morganellaceae 13 10 76.9 | | | | |__ Pectobacteriaceae 8 8 100.0 | | | |__ Alteromonadales 94 94 100.0 | | | | |__ Alteromonadaceae 34 34 100.0 | | | | | |__ Marinobacter 12 12 100.0 | | | | |__ Shewanellaceae 17 17 100.0 | | | | | |__ Shewanella 17 17 100.0 | | | | |__ Pseudoalteromonadaceae 16 16 100.0 | | | | | |__ Pseudoalteromonas 15 15 100.0 | | | | |__ Idiomarinaceae 9 9 100.0 | | | | | |__ Idiomarina 9 9 100.0 | | | | |__ Colwelliaceae 6 6 100.0 | | | |__ Pseudomonadales 81 81 100.0 | | | | |__ Moraxellaceae 41 41 100.0 | | | | | |__ Acinetobacter 25 25 100.0 | | | | | |__ Psychrobacter 8 8 100.0 | | | | | |__ Moraxella 6 6 100.0 | | | | |__ Pseudomonadaceae 40 40 100.0 | | | | | |__ Pseudomonas 38 38 100.0 | | | |__ Oceanospirillales 73 72 98.6 | | | | |__ Oceanospirillaceae
    [Show full text]
  • Journal of Virological Methods Multiplex Real-Time RT-PCR For
    Journal of Virological Methods 266 (2019) 72–76 Contents lists available at ScienceDirect Journal of Virological Methods journal homepage: www.elsevier.com/locate/jviromet Multiplex real-time RT-PCR for detection and distinction of Spondweni and Zika virus T ⁎ Rochelle Rademana, Wanda Markottera, Janusz T. Paweskaa,b, Petrus Jansen van Vurena,b, a Centre of Viral Zoonoses, Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa b Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa ARTICLE INFO ABSTRACT Keywords: Zika (ZIKV) and Spondweni viruses (SPOV) are closely related mosquito borne flaviviruses in the Spondweni Arbovirus serogroup. The co-circulation and similar disease presentation following ZIKV and SPOV infection necessitates Zika virus the development of a diagnostic tool for their simultaneous detection and distinction. We developed a one-step Spondweni virus multiplex real-time RT-PCR (ZIKSPOV) to detect and distinguish between SPOV and ZIKV by utilizing a single Flavivirus primer set combined with virus specific hydrolysis probes. The ZIKSPOV assay was compared to published virus Flaviviridae specific real-time RT-PCR assays and the limit of detection was comparable. The SPOV reference strain AR94 was multiplex Aedes detectable to 0.001 TCID50 per PCR reaction, while African lineage ZIKV (MR 766) was detectable to 0.002 TCID50 per reaction and Asian lineage ZIKV (H/PF/2013) to 0.05 TCID50 per reaction. The ZIKSPOV assay did not detect other flaviviruses, indicative of its specificity for Spondweni serogroup. The ZIKSPOV assay is a useful addition to arbovirus diagnostic and surveillance tools in areas where ZIKV and SPOV are expected to co- circulate.
    [Show full text]
  • Future Developments in Biosensors for Field-Ready Zika Virus Diagnostics Ariana M
    Nicolini et al. Journal of Biological Engineering (2017) 11:7 DOI 10.1186/s13036-016-0046-z REVIEW Open Access Future developments in biosensors for field-ready Zika virus diagnostics Ariana M. Nicolini1†, Katherine E. McCracken2† and Jeong-Yeol Yoon1,2* Abstract Since early reports of the recent Zika virus outbreak in May 2015, much has been learned and discussed regarding Zika virus infection and transmission. However, many opportunities still remain for translating these findings into field-ready sensors and diagnostics. In this brief review, we discuss current diagnostic methods, consider the prospects of translating other flavivirus biosensors directly to Zika virus sensing, and look toward the future developments needed for high-sensitivity and high-specificity biosensors to come. Keywords: Zika, Flaviviruses, Biosensors, RT-PCR, LAMP, Immunoassays Background and Central and North America, has uncovered new Amidst the recent Zika epidemic, rising public health con- insights into rare and severe effects on specific subsets cerns have led to extensive research aimed at uncovering of the population. These include a low risk of Guillain- the underlying mechanisms of Zika virus (ZIKV) infection Barré syndrome in adults, and critical risks for preg- and transmission pathways [1–3]. According to the Pan nant women, including stillbirth, restricted intrauterine American Health Organization (PAHO), autochthonous fetal growth, and microcephaly [7, 10–14]. ZIKV cases in the Americas increased from virtually none As a member of the Flavivirus genus, ZIKV shares many in early 2015 to over 170,000 confirmed and 515,000 common genetic sequences and protein structures with suspected cases by December 2016 [4].
    [Show full text]
  • Taxonomy JN869023
    Species that differentiate periods of high vs. low species richness in unattached communities Species Taxonomy JN869023 Bacteria; Actinobacteria; Actinobacteria; Actinomycetales; ACK-M1 JN674641 Bacteria; Bacteroidetes; [Saprospirae]; [Saprospirales]; Chitinophagaceae; Sediminibacterium JN869030 Bacteria; Actinobacteria; Actinobacteria; Actinomycetales; ACK-M1 U51104 Bacteria; Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae; Limnohabitans JN868812 Bacteria; Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae JN391888 Bacteria; Planctomycetes; Planctomycetia; Planctomycetales; Planctomycetaceae; Planctomyces HM856408 Bacteria; Planctomycetes; Phycisphaerae; Phycisphaerales GQ347385 Bacteria; Verrucomicrobia; [Methylacidiphilae]; Methylacidiphilales; LD19 GU305856 Bacteria; Proteobacteria; Alphaproteobacteria; Rickettsiales; Pelagibacteraceae GQ340302 Bacteria; Actinobacteria; Actinobacteria; Actinomycetales JN869125 Bacteria; Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae New.ReferenceOTU470 Bacteria; Cyanobacteria; ML635J-21 JN679119 Bacteria; Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae HM141858 Bacteria; Acidobacteria; Holophagae; Holophagales; Holophagaceae; Geothrix FQ659340 Bacteria; Verrucomicrobia; [Pedosphaerae]; [Pedosphaerales]; auto67_4W AY133074 Bacteria; Elusimicrobia; Elusimicrobia; Elusimicrobiales FJ800541 Bacteria; Verrucomicrobia; [Pedosphaerae]; [Pedosphaerales]; R4-41B JQ346769 Bacteria; Acidobacteria; [Chloracidobacteria]; RB41; Ellin6075
    [Show full text]
  • Treponema Borrelia Family: Leptospiraceae Genus: Leptospira Gr
    Bacteriology lecture no.12 Spirochetes 3rd class -The spirochetes: are a large ,heterogeneous group of spiral ,motile bacteria. Although, • there are at least eight genera in this family ,only the genera Treponema,Borrelia,and Leptospira which contain organism pathogenic for humans . -There are some reports of intestinal spirochetes ,that have been isolated from biopsy material ,these are Brachyspira pilosicoli,and Brachyspira aalborgi. *Objectives* Taxonomy Order: Spirochaetales Family: Spirochaetaceae Genus: Treponema Borrelia Family: Leptospiraceae Genus: Leptospira -Gram-negative spirochetes -Spirochete from Greek for “coiled hair "they are : *1*Extremely thin and can be very long *2* Motile by periplasmic flagella (axial fibrils or endoflagella) *3*Outer sheath encloses axial fibrils *4*Axial fibrils originate from insertion pores at both poles of cell 1 Bacteriology lecture no.12 Spirochetes 3rd class Spirochaetales Associated Human Diseases Treponema Main Treponema are: - T. pallidum subspecies pallidum - Syphilis: Venereal (sexual) disease 2 Bacteriology lecture no.12 Spirochetes 3rd class - T. pertenue - Yaws Non venereal - T. carateum - Pinta skin disease All three species are morphologically identical Characteristics of T.pallidum 1-They are long ,slender ,helically coiled ,spiral or cork –screw shaped bacilli. 2-T.pallidum has an outer sheath or glycosaminoglycan contain peptidoglycan and maintain the structural integrity of the organisms. 3-Endoflagella (axial filament ) are the flagella-like organelles in the periplasmic space encased by the outer membranes . 4-The endoflagella begin at each end of the organism and wind around it ,extending to and overlapping at the midpoint. 5- Inside the endoflagella is the inner membrane (cytoplasmic membrane)that provide osmotic stability and cover the protoplasmic cylinders .
    [Show full text]
  • Phylogenetic Foundation of Spirochetes
    J. Mol. Microbiol. Biotechnol. (2000) 2(4): 341-344. JMMBSpirochete Symposium Phylogeny on341 Spirochete Physiology Phylogenetic Foundation of Spirochetes Bruce J. Paster* and Floyd E. Dewhirst Spirochaetales that is divided into three families; namely the Spirochaetaceae, the Brachyspiraceae, and the Department of Molecular Genetics, The Forsyth Institute, Leptospiraceae. The phylogenetic relationships of 140 Fenway, Boston, Massachusetts 02115, USA representatives of each genus are shown in Figure 1. The Spirochaetaceae are separated into 6 genera— Borrelia, Brevinema, Cristispira, Spirochaeta, “Spironema”, Abstract and Treponema. New genera of termite spirochetes, such as Clevelandina, Diplocalyx, and Hollandina, have been The spirochetes are free-living or host-associated, described on the basis of differences in ultrastructural traits helical bacteria, some of which are pathogenic to man (Breznak, 1984). It has been suggested that they also and animal. Comparisons of 16S rRNA sequences belong in the family Spirochaetaceae, but no sequence demonstrate that the spirochetes represent a information is presently available to determine their monophyletic phylum within the bacteria. The phylogenetic position within the spirochetes. spirochetes are presently classified in the Class The Brachyspiraceae contain the genus Brachyspira Spirochaetes in the order Spirochetales and are (Serpulina). Due to the close phylogenetic relationship of divided into three major phylogenetic groupings, or B. aarlborgi to species characterized as Serpulina, it has families. The first family Spirochaetaceae contains been recommended that a single genus be justified. Thus, species of the genera Borrelia, Brevinema, Cristispira, Brachyspira takes precedence over Serpulina since the Spirochaeta, Spironema, and Treponema. The second former genus was listed first as a valid name (Hovind- family Brachyspiraceae contains the genus Hougen et al., 1983).
    [Show full text]
  • Chlamydia Trachomatis and Chlamydia Pneumoniae Interaction with the Host: Latest Advances and Future Prospective
    microorganisms Review Chlamydia trachomatis and Chlamydia pneumoniae Interaction with the Host: Latest Advances and Future Prospective Marisa Di Pietro 1,* , Simone Filardo 1 , Silvio Romano 2 and Rosa Sessa 1 1 Department of Public Health and Infectious Diseases, Section of Microbiology, University of Rome “Sapienza”, 00185 Rome, Italy; simone.fi[email protected] (S.F.); [email protected] (R.S.) 2 Cardiology, Department of Life, Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, Italy; [email protected] * Correspondence: [email protected] Received: 15 April 2019; Accepted: 14 May 2019; Published: 16 May 2019 Abstract: Research in Chlamydia trachomatis and Chlamydia pneumoniae has gained new traction due to recent advances in molecular biology, namely the widespread use of the metagenomic analysis and the development of a stable genomic transformation system, resulting in a better understanding of Chlamydia pathogenesis. C. trachomatis, the leading cause of bacterial sexually transmitted diseases, is responsible of cervicitis and urethritis, and C. pneumoniae, a widespread respiratory pathogen, has long been associated with several chronic inflammatory diseases with great impact on public health. The present review summarizes the current evidence regarding the complex interplay between C. trachomatis and host defense factors in the genital micro-environment as well as the key findings in chronic inflammatory diseases associated to C. pneumoniae. Keywords: Chlamydia trachomatis; Chlamydia pneumoniae; host-pathogen interaction 1. Introduction Currently, there is a renewed research interest in Chlamydiae that cause a broad spectrum of pathologies of varying severity in human, mainly Chlamydia trachomatis and Chlamydia pneumoniae [1,2]. Advances in molecular biology and, in particular, the recent advent of metagenomic analysis as well as the development of a stable genomic transformation system in Chlamydiae have significantly contributed to expanding our understanding of Chlamydia pathogenesis [3–5].
    [Show full text]
  • Leptospira Noguchii and Human and Animal Leptospirosis, Southern Brazil
    LETTERS Leptospira noguchii previously isolated from animals such titer of 25 against saprophytic sero- as armadillo, toad, spiny rat, opossum, var Andamana by MAT. Both patients and Human and nutria, the least weasel (Mustela niva- were from the rural area of Pelotas. Animal Leptospirosis, lis), cattle, and the oriental fi re-bellied Unfortunately, convalescent-phase se- Southern Brazil toad (Bombina orientalis) in Argen- rum samples were not obtained from tina, Peru, Panama, Barbados, Ni- these patients. To the Editor: Pathogenic lep- caragua, and the United States (1,6). A third isolate (Hook strain) was tospires, the causative agents of lep- Human leptospirosis associated with obtained from a male stray dog with tospirosis, exhibit wide phenotypic L. noguchii has been reported only in anorexia, lethargy, weight loss, disori- and genotypic variations. They are the United States, Peru, and Panama, entation, diarrhea, and vomiting. The currently classifi ed into 17 species and with the isolation of strains Autum- animal died as a consequence of the >200 serovars (1,2). Most reported nalis Fort Bragg, Tarassovi Bac 1376, disease. The isolate was obtained from cases of leptospirosis in Brazil are of and Undesignated 2050, respectively a kidney tissue culture. No temporal urban origin and caused by Leptospira (1,6). The Fort Bragg strain was iso- or spatial relationship was found be- interrogans (3). Brazil underwent a lated during an outbreak among troops tween the 3 cases. dramatic demographic transformation at Fort Bragg, North Carolina. It was Serogrouping was performed by due to uncontrolled growth of urban identifi ed as the causative agent of an using a panel of rabbit antisera.
    [Show full text]
  • Efficacy of Clostridium Bifermentans Serovar Malaysia on Target and Nontarget Organisms
    Journal of the American Mosquito Control Association, lO(I):51-55,1994 Copyright @ 1994 by the American Mosquito Control Association, Inc. EFFICACY OF CLOSTRIDIUM BIFERMENTANS SEROVAR MALAYSIA ON TARGET AND NONTARGET ORGANISMS M. YIALLOUROS,T V. STORCH,: I. THIERYT erp N. BECKERI ABSTRACT. Clostridium bifermentansserovar malaysia (C.b.m.) is highly toxic to mosquito larvae. In this study, the following aquatic nontarget invertebrateswere treated with high C.b.,,?.concentrations (up to 1,600-fold the toxic concentration for Anophelesstephensi) to study their susceptibility towards the bacterial toxrn: Planorbis planorbis (Pulmonata); Asellus aquaticzs (Isopoda); Daphnia pulex (Cla- docera);Cloeon dipterun (Ephemeroptera);Plea leachi (Heteroptera);and Eristalis sp., Chaoboruscrys' tallinus, Chironomus thummi, and Psychodaalternata (Diptera). In addition, bioassayswere performed with mosquito Larvae(Aedes aegypti, Anopheles stephensi, and Culex pipiens). Psychodaalternatalamae were very susc€ptible,with LCro/LCro values comparable to those of mosquito larvae (about 103-105 spores/ml). The tests with Chaoboruscrystallinus larvae showed significant mortality rates at high con- centrations,but generallynot before 4 or 5 days after treatment. The remaining nontargetorganisms did not show any susceptibility.The investigation confirms the specificityof C.b.m.lo nematocerousDiptera. INTRODUCTION strains of Aedesaegypti (Linn ) larvae, which are about I 0 times lesssensitiv e than A nophe I e s. The For several years, 2larvicidal bacteia, Bacil- LCr' (48 h) rangesfrom 5 x 103to 2 x lOscells/ lus thuringiensls Berliner var. israelensis (B.t.i.) ml (Thiery et al. 1992b).Larvae of Simulium and Bacillus sphaericus Neide, have been used speciesseem to be less susceptible(de Barjac et successfully for mosquito and blackfly control all al.
    [Show full text]
  • Genetic Diversity in Treponema Pallidum: Implications for Pathogenesis, Evolution and Molecular Diagnostics of Syphilis and Yaws ⇑ David Šmajs A, , Steven J
    Infection, Genetics and Evolution 12 (2012) 191–202 Contents lists available at SciVerse ScienceDirect Infection, Genetics and Evolution journal homepage: www.elsevier.com/locate/meegid Review Genetic diversity in Treponema pallidum: Implications for pathogenesis, evolution and molecular diagnostics of syphilis and yaws ⇑ David Šmajs a, , Steven J. Norris b, George M. Weinstock c a Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00 Brno, Czech Republic b Department of Pathology and Laboratory Medicine, University of Texas Medical School at Houston, 6431 Fannin Street, Houston, TX 77030, USA c The Genome Institute, Washington University, 4444 Forest Park Avenue, Campus Box 8501, St. Louis, MO 63108, USA article info abstract Article history: Pathogenic uncultivable treponemes, similar to syphilis-causing Treponema pallidum subspecies pallidum, Received 21 September 2011 include T. pallidum ssp. pertenue, T. pallidum ssp. endemicum and Treponema carateum, which cause yaws, Received in revised form 5 December 2011 bejel and pinta, respectively. Genetic analyses of these pathogens revealed striking similarity among Accepted 7 December 2011 these bacteria and also a high degree of similarity to the rabbit pathogen, Treponema paraluiscuniculi,a Available online 15 December 2011 treponeme not infectious to humans. Genome comparisons between pallidum and non-pallidum trepo- nemes revealed genes with potential involvement in human infectivity, whereas comparisons between Keywords: pallidum and pertenue treponemes identified genes possibly involved in the high invasivity of syphilis Treponema pallidum treponemes. Genetic variability within syphilis strains is considered as the basis of syphilis molecular Treponema pallidum ssp. pertenue Treponema pallidum ssp. endemicum epidemiology with potential to detect more virulent strains, whereas genetic variability within a single Treponema paraluiscuniculi strain is related to its ability to elude the immune system of the host.
    [Show full text]